Neuronal Responses to Social Feedback in Major Depressive Disorder
NCT ID: NCT02180607
Last Updated: 2015-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
58 participants
OBSERVATIONAL
2013-10-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers of Social Sensitivity in Major Depression
NCT02214511
Probing Prefrontal Cortex Hemodynamic Alterations for Major Depression Disorder
NCT03595020
Endogenous Opioid Mechanisms for Rejection Sensitivity
NCT02189785
Using Affective Differences to Predict Response to Behavioral Treatment for Major Depressive Disorder
NCT00909220
Neural Mechanism Underlying Social Cognition in Depressive Patients
NCT03413670
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Controls
Response to social feedback, monetary incentive delay, and go/no-go tasks
No interventions assigned to this group
MDD patients
Response to social feedback, monetary incentive delay, and go/no-go tasks
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No use of psychotropic medications in the past 4 weeks
* No regular tobacco use, and who are able to make decisions for his or her self -Patients who meet criteria for (DSM-IV) Major Depressive Disorder or Depressive Disorder Not Otherwise Specified, with Hamilton Depression Rating Scale scores ≥ 10, and may be on monotherapy (treatment for MDD with a single SSRI)
* MDD patients will be matched with healthy controls for age and education.
Exclusion Criteria
* History of DSM-IV alcohol or drug dependence within the past 5 years
* Drug or alcohol abuse in the past 2 years or a CAGE Alcohol Screening Inventory score of \>3
* Regular alcohol use during the past 6 months equal to or greater than 16 cans of beer per week or equivalent; use of street drugs during the past 2 years
* Regular tobacco use, since nicotine stimulates cortisol secretion even in smokers;
* Major chronobiological disruption or phase shift during the preceding month (e.g., total sleep deprivation, reversal of sleep-wake cycles or trans-meridian travel)
* Childbirth or miscarriage within 6 months
* Breastfeeding within 6 months of recruitment
* Progestin-only birth controls (e.g., Cerazette, Ovrette)
* No contraindications to MRI scan including neurostimulators, metal in the body, weight over 250 pounds, and girth size incompatible for MRI scanner bore
* No non-right-handed subjects
* For healthy controls, subjects will have no history of psychiatric problems in themselves or any first-degree relatives
18 Years
55 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
David Hsu
Research Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David T Hsu, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.